SOURCE: Ceelox, Inc.

October 04, 2010 08:30 ET

Ceelox Update: Company Continues to Evolve Growth Strategy

TAMPA, FL--(Marketwire - October 4, 2010) -  Ceelox, Inc., (OTCBB: CELO), (the "Company"), continues to focus on evolving their product line and company strategy to meet changes in the competitive landscape. With the recent announcements regarding industry consolidation, Ceelox has been aggressive in their product evolution and pursuit of a strategic partner.

Over the last few weeks, the company has released announcements regarding progress developing and advancing their solutions to fight cybercrime and secure core systems access in the enterprise. To date, this year Ceelox has:

  • Announced that its biometric unit software for identity authentication across a network utilizing the Windows Biometric Framework has earned the "Compatible with Windows 7" logo for Microsoft's new operating system. As a result, the company will have products working across all three Microsoft platforms: XP, Vista, and Windows 7. The company will work aggressively to take advantage of the Microsoft Partner Program and its 600,000 partners across the globe.

  • Ceelox's ID Server Edition has been recognized as Citrix Ready with a solution providing biometric authentication on a thin client or a PC to the virtual machine running in a Citrix server. The company will leverage this recognition to gain exposure to over 230,000 Citrix customers, and 8,000 Citrix Solutions Provider Partners world wide.

  • The Company completed its first significant Citrix deployment developing a manufacturing solution to utilize biometric authentication as a solution to stage controls within the production process significantly reducing cycle time and has recently deployed its solution within the pharmaceutical industry. Ceelox expects to leverage the Citrix certification and the success with the manufacturing solution and is expecting further Ceelox ID Server Edition deployments in Citrix shops.

The company also continues their efforts to identify a strategic partner which complements its biometric authentication and data security software products. Ceelox has engaged investment banking firm, Laidlaw & Company, to provide financial advisory and investment banking services and to provide advice on strategic transactions. "We have the highest confidence in Laidlaw. Their history in the banking world coupled with our products and intellectual property should ensure a good fit with the substantial opportunity existing in the authentication and data security industry," stated Gerry Euston, CEO Ceelox, Inc. The engagement of Laidlaw is consistent with the Company's strategic growth strategy.

About Ceelox, Inc.

Ceelox, Inc. is a developer of biometric security and encryption software solutions for financial institutions, healthcare companies, utilities, government agencies and other organizations for whom information access are key concerns. Its security and encryption tools are easy to deploy, simple to use, cost-effective and affordable for organizations of all sizes.

Notice Regarding Forward-Looking Statements

This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factor disclosure outlined in our Form 8-K filed with the Securities and Exchange Commission on February 12, 2010 and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

For more information visit our website at www.ceelox.com

Contact Information